FAERStisotumab vedotin

JuanJuan Li1, Yang Zhao1, Xueqin Yang1

  • 1Department of Pharmacy, Guangyuan Central Hospital, Guanyuan, China.

Scientific reports
|August 18, 2025
PubMed
概括

抗体-药物结合物tisotumab vedotin (TV) 在宫癌患者中显示了真实世界的不良事件 (AE). 眼睛和血液/淋巴系统疾病最常见,发现了白内障等新信号.